Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Mar 18;333(11):950-961.
doi: 10.1001/jama.2024.25056.

Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers: The D-CARE Randomized Clinical Trial

Collaborators, Affiliations
Multicenter Study

Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers: The D-CARE Randomized Clinical Trial

David B Reuben et al. JAMA. .

Erratum in

  • Omitted Grant Numbers.
    [No authors listed] [No authors listed] JAMA. 2025 May 6;333(17):1549. doi: 10.1001/jama.2025.4753. JAMA. 2025. PMID: 40193097 Free PMC article. No abstract available.

Abstract

Importance: The effectiveness of different approaches to dementia care is unknown.

Objective: To determine the effectiveness of health system-based, community-based dementia care, and usual care for persons with dementia and for caregiver outcomes.

Design, setting, and participants: Randomized clinical trial of community-dwelling persons living with dementia and their caregivers conducted at 4 sites in the US (enrollment June 2019-January 2023; final follow-up, August 2023).

Interventions: Participants were randomized 7:7:1 to health system-based care provided by an advanced practice dementia care specialist (n = 1016); community-based care provided by a social worker, nurse, or licensed therapist care consultant (n = 1016); or usual care (n = 144).

Main outcomes and measures: Primary outcomes were caregiver-reported Neuropsychiatric Inventory Questionnaire (NPI-Q) severity score for persons living with dementia (range, 0-36; higher scores, greater behavioral symptoms severity; minimal clinically important difference [MCID], 2.8-3.2) and Modified Caregiver Strain Index for caregivers (range, 0-26; higher scores, greater strain; MCID, 1.5-2.3). Three secondary outcomes included caregiver self-efficacy (range, 4-20; higher scores, more self-efficacy).

Results: Among 2176 dyads (individuals with dementia, mean age, 80.6 years; 58.4%, female; and 20.6%, Black or Hispanic; caregivers, mean age, 65.2 years; 75.8%, female; and 20.8% Black or Hispanic), primary outcomes were assessed for more than 99% of participants, and 1343 participants (62% of those enrolled and 91% still alive and had not withdrawn) completed the study through 18 months. No significant differences existed between the 2 treatments or between treatments vs usual care for the primary outcomes. Overall, the least squares means (LSMs) for NPI-Q scores were 9.8 for health system, 9.5 for community-based, and 10.1 for usual care. The difference between health system vs community-based care was 0.30 (97.5% CI, -0.18 to 0.78); health system vs usual care, -0.33 (97.5% CI, -1.32 to 0.67); and community-based vs usual care, -0.62 (97.5% CI, -1.61 to 0.37). The LSMs for the Modified Caregiver Strain Index were 10.7 for health system, 10.5 for community-based, and 10.6 for usual care. The difference between health system vs community-based care was 0.25 (97.5% CI, -0.16 to 0.66); health system vs usual care, 0.14 (97.5% CI, -0.70 to 0.99); and community-based vs usual care, -0.10 (97.5% CI, -0.94 to 0.74). Only the secondary outcome of caregiver self-efficacy was significantly higher for both treatments vs usual care but not between treatments: LSMs were 15.1 for health system, 15.2 for community-based, and 14.4 for usual care. The difference between health system vs community-based care was -0.16 (95% CI, -0.37 to 0.06); health system vs usual care, 0.70 (95% CI, 0.26-1.14); and community-based vs usual care, 0.85 (95% CI, 0.42 to 1.29).

Conclusions and relevance: In this randomized trial of dementia care programs, no significant differences existed between health system-based and community-based care interventions nor between either active intervention or usual care regarding patient behavioral symptoms and caregiver strain.

Trial registration: ClinicalTrials.gov Identifier: NCT03786471.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Williamson reported receiving grants from the Alzheimer's Association during the conduct of the study. Dr Lichtenstein reported receiving grants from Eisai outside the submitted work. Dr Bass reported being an employee of Benjamin Rose Institute. Dr Weitzman reported being an employee of Bemjamin Rose Institute. Ms Currie reported receiving grants from the NIH outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. D-CARE Recruitment, Enrollment, Assignment to Treatment Group, and Follow-Up
aEach person living with dementia and caregiver. bRandomization (7:7:1) was stratified by site. cThe 12-item Neuropsychiatric Inventory Questionnaire (NPI-Q) severity scale (range, 0-36, higher scores indicate greater severity of behavioral symptoms. dThe 13-item Modified Caregiver Strain Index (MCSI) score ranges from 0 to 26, with higher scores indicating greater strain.
Figure 2.
Figure 2.. Primary and Secondary Outcomes by Treatment Group
Primary and secondary outcomes are plotted by assessment time point. Boxes indicate IQRs; bars inside the boxes, medians; circles inside boxes, means; whiskers, highest and lowest values within 1.5 times the IQR; and circles beyond the whiskers, outliers. Caregiver self-efficacy was not ascertained at the 3-month or 12-month assessments. Raw and least-squares means of primary and secondary outcomes by time point are also presented in eTables 3 (primary) and 4 (secondary) in Supplement 3. For the Caregiver Self-Efficacy (CSE), Modified Caregiver Strain Index (MCSI), Neuropsychiatric Inventory Questionnaire (NPI-Q) severity and distress, and Patient Health Questionnaire–8 (PHQ-8) score ranges, see the footnotes in Tables 2 and 3.

Comment in

References

    1. 2024. Alzheimer’s disease facts and figures. Accessed April 20, 2024. https://www.alz.org/alzheimers-dementia/facts-figures - PMC - PubMed
    1. Manly JJ, Jones RN, Langa KM, et al. Estimating the prevalence of dementia and mild cognitive impairment in the US: the 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project. JAMA Neurol. 2022;79(12):1242-1249. - PMC - PubMed
    1. Lees Haggerty K, Epstein-Lubow G, Spragens LH, et al. Recommendations to improve payment policies for comprehensive dementia care. J Am Geriatr Soc. 2020;68(11):2478-2485. - PubMed
    1. Reuben DB, Gill TM, Stevens A, et al. D-CARE: the Dementia Care Study: design of a pragmatic trial of the effectiveness and cost effectiveness of health system-based versus community-based dementia care versus usual dementia care. J Am Geriatr Soc. 2020;68(11):2492-2499. - PMC - PubMed
    1. Yang M, Samper-Ternent R, Volpi E, et al. The Dementia Care Study (D-CARE): recruitment strategies and demographic characteristics of participants in a pragmatic randomized trial of dementia care. Alzheimers Dement. 2024;20(4):2575-2588. - PMC - PubMed

Publication types

Associated data